Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy-Reference-Cited by-同舟云学术

Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy

Published:2016-01-11 Issue:1 Volume:53 Page:174-181
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Kwon Hyemi,Kim Won Gu,Jeon Min Ji,Song Dong Eun,Lee Yu-Mi,Sung Tae-Yon,Chung Ki-Wook,Yoon Jong Ho,Hong Suck Joon,Baek Jung Hwan,Lee Jeong Hyun,Kim Tae Yong,Kim Won Bae,Shong Young Kee

Funder

Bumsuck Academic Research Fund

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s12020-015-0849-6.pdf

Reference24 articles.

1. S.A. Wells Jr, S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel, N. Lee, A. Machens, J.F. Moley, F. Pacini, F. Raue, K. Frank-Raue, B. Robinson, M.S. Rosenthal, M. Santoro, M. Schlumberger, M. Shah, S.G. Waguespack, Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25(6), 567–610 (2015). doi: 10.1089/thy.2014.0335

2. P. Fallahi, S.M. Ferrari, F.D. Bari, G. Materazzi, S. Benvenga, P. Miccoli, A. Antonelli, Cabozantinib in thyroid cancer. Recent Pat. Anticancer Drug Discov. 10(3), 259–269 (2015)

3. P. Fallahi, F. Di Bari, S.M. Ferrari, R. Spisni, G. Materazzi, P. Miccoli, S. Benvenga, A. Antonelli, Selective use of vandetanib in the treatment of thyroid cancer. Drug Des. Dev. Ther. 9, 3459–3470 (2015). doi: 10.2147/dddt.s72495

4. S. Roman, R. Lin, J.A. Sosa, Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer 107(9), 2134–2142 (2006). doi: 10.1002/cncr.22244

5. E. Kebebew, P.H. Ituarte, A.E. Siperstein, Q.Y. Duh, O.H. Clark, Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88(5), 1139–1148 (2000)

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fundamentals and recent advances in the evaluation and management of medullary thyroid carcinoma;Molecular and Cellular Endocrinology;2024-10

2. Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update;Cancer Management and Research;2024-04

3. Prognostic Factors and Long-Term Outcomes of Medullary Thyroid Microcarcinoma in a Retrospective Cohort Study;Clinical Thyroidology®;2023-11-01

4. Medulläres Schilddrüsenkarzinom;Angewandte Nuklearmedizin;2023-08-28

5. Clinical Evolution of Sporadic Medullary Thyroid Carcinoma With Biochemical Incomplete Response After Initial Treatment;The Journal of Clinical Endocrinology & Metabolism;2023-02-01